Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest

Journal of Infection and Chemotherapy

Volumn 6, Issue 1, 2000, Pages 30-34

  Horii, Toshinobu ^a   Kimura, Taku ^a   Odagiri, Takuya ^a   Shibayania, Keigo ^a   Ohta, Michio ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Escherichia coli; Etest; Fosfomycin; Susceptibility test

Indexed keywords

FOSFOMYCIN; GLUCOSE 6 PHOSPHATE;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; CULTURE MEDIUM; DRUG DETERMINATION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0034096428     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101560050046     Document Type: Article

References (13)

1. Takeda T, Yoshino K, Uchida H, Ikeda N, Tanimura M. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. In: Kaper J, O'Brien AD. Washington, DC: American Society for Microbiology, 1998:385-7.
2. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991;29:2072-5.
3. Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol 1996;34:1880-4.
4. Biedenbach DJ, Schermer IH, Jones RN. Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices. Diagn Microbiol Infect Dis 1997;27:1-5.
5. Hoogkamp-Korstanje JAA, Dirks-Go SIS, Kabel P, Manson WL, Stobberingh EE, Vreede RW, et al. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. J Antimicrob Chemother 1997;39:411-4.
6. Marshall SA, Rhomberg PR, Jones RN. Comparative evaluation of Etest for susceptibility testing of Neisseria meningitidis with eight antimicrobial agents. An investigation using US Food and Drug Administration regulatory criteria. Diagn Microbiol Infect Dis 1997;27:93-7.
7. Inouye S, Watanabe T, Tsuruoka T, Kitasato I. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions. J Antimicrob Chemother 1989;24:657-66.
8. Goto S, Dogasaki I, Kaneko Y, Ogawa M, Takita T, Kuwahara S. In vitro and in vivo antibacterial activity of fosfomycin. Chemotherapy 1975;23:1653-61.
9. Citron DM, Ostovari MI, Karlsson A, Goldstein EJC. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 1991;29:2197-203.
10. Huang MB, Gay TE, Baker CN, Banerjee SN, Tenover FC. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods. J Clin Microbiol 1993;31:2683-8.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed. Approved Standard M7-A3. Villanova, PA: NCCLS, 1993.
12. Kahan FM, Kahan JS, Cassidy PJ, Kroop H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 1974;235:364-85.
13. Horii T, Kimura T, Sato K, Shibayama K, Ohta M. Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26. Antimicrob Agents Chemother 1999;43:789-93.